Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
291
days
Considerations on Interim Evaluation of OS in Pivotal Oncology Trials
Authors
Weidong Zhang; Sunhee Ro; Jing Zhao; Xiaoyun Li; Qi Jiang; Linda Sun; Olga Marchenko; Chengxing (Cindy) Lu; Rong Liu; on behalf of the Interim Evaluation of OS Workstream of the Statistical Methods in Oncology Scientific Working Group, Biopharmaceutical Section, American Statistical AssociationShow moreShow less
Affiliations
1. Sana Biotechnology; 2. Nurix Therapeutics; 3. Merck & Co; 4. BeOne Medicines; 5. Pfizer Inc; 6. Bayer; 7. AstraZeneca Plc; 8. Regeneron Pharmaceuticals IncShow moreShow less
350
days
Minimizing Harm: Optimal Monitoring Boundaries When Harm is Present
Authors
Jonathon Vallejo; Shu WangShow moreShow less
Affiliations
1. Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug AdministrationShow moreShow less
505
days
A Bayesian Latent Subgroup Design for Basket Trials with Survival Endpoints
Authors
Yueyang Han; Haolun ShiShow moreShow less
Affiliations
1. Department of Statistics and Actuarial Science, Simon Fraser UniversityShow moreShow less
268
days
Novel Statistical Designs and Considerations to Support Diversity and Inclusion in Clinical Trials
Authors
Feng Tian; Meizi Liu; Yunqi Zhao; Jianchang Lin; Rachael LiuShow moreShow less
Affiliations
1. University of Texas MD Anderson Cancer Center; 2. Takeda PharmaceuticalsShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
